SOTERA HEALTH COMPANY

(SHC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2020 2021 2022 2023 2024
Capitalization1 7 8026 6635 439--
Enterprise Value (EV)1 9 5608 3416 8696 7166 501
P/E ratio -172x57,4x30,9x22,9x19,6x
Yield -----
Capitalization / Revenue 9,54x7,15x5,33x4,90x4,50x
EV / Revenue 11,7x8,95x6,73x6,05x5,38x
EV / EBITDA 22,8x17,3x13,2x11,4x9,96x
Price to Book 14,4x11,4x6,09x5,04x4,11x
Nbr of stocks (in thousands) 284 321282 917282 817--
Reference price (USD) 27,423,619,219,219,2
Announcement Date 03/09/202103/01/2022---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 7788189311 0201 1101 207
EBITDA1 -420481522587653
Operating profit (EBIT)1 -357417451518571
Operating Margin -43,6%44,8%44,2%46,7%47,3%
Pre-Tax Profit (EBT) --38,9176---
Net income1 -20,9-38,6117174236278
Net margin -2,68%-4,72%12,5%17,1%21,2%23,0%
EPS2 --0,160,410,620,840,98
Dividend per Share2 ------
Announcement Date 09/02/202003/09/202103/01/2022---
1 USD in Million
2 USD
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales1 226241237256256271
EBITDA1 117125115131132142
Operating profit (EBIT)1 10010899,5114115125
Operating Margin 44,3%44,8%42,0%44,4%44,7%46,0%
Pre-Tax Profit (EBT) ------
Net income1 27,436,030,642,544,751,6
Net margin 12,1%14,9%12,9%16,6%17,4%19,1%
EPS2 0,100,130,110,160,170,19
Dividend per Share ------
Announcement Date 11/10/202103/01/202205/05/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 -1 7581 6791 4301 2771 063
Net Cash position1 ------
Leverage (Debt / EBITDA) -4,19x3,49x2,74x2,17x1,63x
Free Cash Flow1 -67,1179229322416
ROE (Net Profit / Equities) --47,3%38,2%34,7%30,8%
Shareholders' equity1 --247456678904
ROA (Net Profit / Asset) -3,71%8,86%10,5%11,8%11,6%
Assets1 --1 0411 3201 6631 9922 393
Book Value Per Share2 -1,902,073,163,824,68
Cash Flow per Share -0,510,37---
Capex1 -53,5102154121104
Capex / Sales -6,54%11,0%15,1%10,9%8,61%
Announcement Date 09/02/202003/09/202103/01/2022---
1 USD in Million
2 USD
Estimates
Key data
Capitalization (USD) 5 438 575 409
Net sales (USD) 931 478 000
Number of employees 3 000
Sales / Employee (USD) 310 493
Free-Float 96,0%
Free-Float capitalization (USD) 5 223 121 594
Avg. Exchange 20 sessions (USD) 9 862 497
Average Daily Capital Traded 0,18%
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA